Literature DB >> 26497593

Presence of an intracompartmental septum detected by ultrasound is associated with the failure of ultrasound-guided steroid injection in de Quervain's syndrome.

E De Keating-Hart1, S Touchais1, Y Kerjean2, L Ardouin2, B Le Goff3.   

Abstract

UNLABELLED: The purpose of this study was to find clinical or ultrasound characteristics that might predict the failure of conservative treatment in de Quervain's syndrome. A total of 42 ultrasound-guided injections have been performed in 41 patients after clinical and ultrasound examination. Patients were immobilized for 3 weeks with a spica splint cast, and clinically evaluated at 3 and 6 weeks and by phone call at the end of the study. Ultrasound showed a septum between the tendons of the first comportment in 34% of the wrists. At last follow-up (mean 15.6 months after the injection) ten patients (24%) had undergone surgery. When comparing ultrasound and clinical characteristics of the operated and non-operated wrists, we found that patients with a high baseline visual analogue scale, with all positive clinical tests and with a persistent intracompartmental septum, had a significantly higher risk of failure following conservative treatment. LEVEL OF EVIDENCE: III.
© The Author(s) 2015.

Entities:  

Keywords:  De Quervain’s syndrome; prospective study; steroid injection; ultrasound-guided injection

Mesh:

Substances:

Year:  2015        PMID: 26497593     DOI: 10.1177/1753193415611414

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  6 in total

1.  Diagnostic accuracy of imaging modalities in the detection of clinically diagnosed de Quervain's syndrome: a systematic review.

Authors:  Brodwen McBain; Ebonie Rio; Jill Cook; Rafal Grabinski; Sean Docking
Journal:  Skeletal Radiol       Date:  2019-03-19       Impact factor: 2.199

2.  Sex differences in the radial grooves in the first extensor compartment.

Authors:  Ilke A Gurses; Rustu Turkay; Ercan Inci; Suna Ors; Yilmaz Onal; Sevda Ozel; Meltem Vural
Journal:  Skeletal Radiol       Date:  2016-04-04       Impact factor: 2.199

3.  Ultrasound-guided steroid injection for the treatment of de Quervain's disease: an anatomy-based approach.

Authors:  Jong-Hyun Bing; Soo-Jung Choi; Seung-Moon Jung; Dae-Shick Ryu; Jae-Hong Ahn; Chae-Hoon Kang; Dong-Rock Shin
Journal:  Skeletal Radiol       Date:  2018-05-05       Impact factor: 2.199

4.  Prevalence of a Septated First Dorsal Compartment Among Patients With and Without De Quervain Tenosynovitis: An In Vivo Anatomical Study.

Authors:  Bryan G Beutel; Matthew E Doscher; Charles P Melone
Journal:  Hand (N Y)       Date:  2018-11-15

5.  Clinical indications for image-guided interventional procedures in the musculoskeletal system: a Delphi-based consensus paper from the European Society of Musculoskeletal Radiology (ESSR)-Part II, elbow and wrist.

Authors:  Luca Maria Sconfienza; Miraude Adriaensen; Domenico Albano; Maria Pilar Aparisi Gómez; Alberto Bazzocchi; Ian Beggs; Bianca Bignotti; Vito Chianca; Angelo Corazza; Danoob Dalili; Miriam De Dea; Jose Luis Del Cura; Francesco Di Pietto; Eleni Drakonaki; Fernando Facal de Castro; Dimitrios Filippiadis; Jan Gielen; Salvatore Gitto; Harun Gupta; Andrea S Klauser; Radhesh Lalam; Silvia Martin; Carlo Martinoli; Giovanni Mauri; Catherine McCarthy; Eugene McNally; Kalliopi Melaki; Carmelo Messina; Rebeca Mirón Mombiela; Benedikt Neubauer; Marina Obradov; Cyprian Olchowy; Davide Orlandi; Athena Plagou; Raquel Prada Gonzalez; Saulius Rutkauskas; Ziga Snoj; Alberto Stefano Tagliafico; Alexander Talaska; Violeta Vasilevska-Nikodinovska; Jelena Vucetic; David Wilson; Federico Zaottini; Marcello Zappia; Georgina Allen
Journal:  Eur Radiol       Date:  2019-12-16       Impact factor: 5.315

6.  Is a Steroid Injection in Both Compartments More Effective than an Injection in the Extensor Pollicis Brevis Subcompartment Alone in Patients with de Quervain Disease? A Randomized, Controlled Trial.

Authors:  Hyoung-Seok Jung; Suk Ho Baek; Jae Sung Lee
Journal:  Clin Orthop Relat Res       Date:  2022-04-01       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.